Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
培养坦桑尼亚营养不良和结核病交叉领域的研究领导者
基本信息
- 批准号:10875013
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AfricaCareer ChoiceCollaborationsCommunicable DiseasesCommunicationCompensationCompetenceCounselingCountryDiseaseEconomicsEquityFacultyGoalsGrantHealth SciencesImmunosuppressionInfectious Diseases ResearchInternshipsLeadLeadershipMalnutritionMapsMentorshipMethodsNeeds AssessmentPostdoctoral FellowRecommendationReportingResearchResearch PersonnelResearch TrainingSchoolsScientistStudentsTanzaniaTrainingTraining ProgramsTravelTuberculosisUnderrepresented MinorityUnderrepresented StudentsUnited NationsUniversitiesVirginiaWagesWorld Health OrganizationWritingcareerdesignexperienceglobal healthhands on researchinterestprogramsrecruitscale upskillssocialtuberculosis treatmentundergraduate studentuniversity studentvirtual
项目摘要
ABSTRACT/ SUMMARY
In non-pandemic periods, tuberculosis (TB) is the leading killer worldwide from a curable infectious disease.
Malnutrition related immunosuppression is the most important driver of conversion from latent Mycobacterium
tuberculosis infection to active TB disease. Yet TB disease itself worsens malnutrition, while the physical,
social and economic consequences of TB treatment all predispose to sequelae of persistent malnutrition. The
United Nations and World Health Organization’s End TB Strategy recommends scaling-up of research training
of scientists in TB endemic settings skilled in the End TB research goals. Given that researchers and
educators from the University of Virginia (UVA) and Tanzania are currently working in collaborative research in
multiple domains of malnutrition and TB, we performed a countrywide needs assessment to map the
competencies of successful research leaders identified in the Path to Research Leadership Report in Africa
2020. We then designed the current Global Infectious Diseases Research Training Program (GIDRTP- D43
TW012247, now grant year 2), to train 6 postdoctoral Tanzanian scientists in research leadership excellence at
the intersection of malnutrition and TB, and within the components of research team management,
communication, grant writing, professionalism and career trajectory. Tanzanian postdoctoral scientists receive
3 years of salary support, mentorship with UVA and Tanzanian faculty at strategic institutes, and lead a team
of staff scientists, Tanzanian Master’s students, and undergraduate students from UVA (2 per postdoctoral
scientist led team) utilizing the eGlobal program of virtual/online engagement.
While interest is high for undergraduates across varied schools at UVA for participation in the GIDRTP and
eGlobal program, the majority have prior global travel experience and do not identify as underrepresented in
health sciences. Furthermore, the current eGlobal program does not provide a summative travel experience to
Tanzania. This supplement will 1) recruit and retain 8 new undergraduate students that are underrepresented
in health sciences for a year’s longitudinal internship in global research engagement and a summative hands-
on research experience in Tanzania with their Tanzanian postdoctoral scientist-led team; 2) do so through
equitable compensation of stipend during the internship; 3) provide UVA faculty led training for undergraduates
in global health career tracks, methods of cross-cultural research collaboration, and pre/post travel counseling;
and 4) advance the research team leadership skills of the Tanzanian postdoctoral scientists following the
integration of undergraduates with diverse lived backgrounds. We expect this adaptation of the eGlobal
program for underrepresented minorities in global health sciences can be scaled to other training programs
and scientific foci.
摘要/摘要
在非大流行时期,结核病(TB)是全世界的主要杀手,来自健康的传染病。
与营养不良有关的免疫抑制是潜在的分枝杆菌转化的最重要驱动因素
结核病感染活性结核病。然而,结核病本身会恶化营养不良,而身体则恶化
结核病治疗的社会和经济后果均易于持续营养不良的后遗症。
联合国和世界卫生组织的结束结核病战略建议扩大研究培训
结核病内粒环境中的科学家最终熟练于结核病研究目标。鉴于研究人员和
弗吉尼亚大学(UVA)和坦桑尼亚的教育工作者目前正在从事合作研究
营养不良和结核病的多个领域,我们进行了全国需求评估,以绘制
在非洲研究领导力报告中确定的成功研究领导者的能力
2020年。然后,我们设计了当前的全球传染病研究培训计划(GIDRTP-D43
TW012247,现已授予2年),培训6个坦桑尼亚博士后科学家在研究领导力卓越的研究领导
营养不良与结核病的交集,以及研究团队管理的组成部分,
沟通,赠款写作,专业和职业轨迹。坦桑尼亚博士后科学家接受
战略机构的UVA和坦桑尼亚教职员工的薪水支持3年,领导团队
来自UVA的员工科学家,坦桑尼亚硕士的学生和本科生(每人2个
科学家LED团队)使用虚拟/在线参与的Eglobal计划。
虽然UVA各种学校的本科生的兴趣很高,以参加GIDRTP和
Eglobal计划,大多数具有以前的全球旅行经验,并且没有确定为不足的人数
健康科学。此外,当前的Eglobal计划没有为
坦桑尼亚。该补充剂将为1)招募和保留8位新的本科生的人数不足
一年在全球研究参与方面的纵向实习的卫生科学领域,
关于坦桑尼亚的研究经验以及坦桑尼亚的博士后科学家团队; 2)这样做
实习期间的公平压力赔偿; 3)为大学生提供UVA教师LED培训
在全球健康职业轨道上,跨文化研究合作的方法以及旅行前/旅行咨询;
4)提高坦桑尼亚博士后科学家的研究团队领导技能
将大学生与潜水员的现场背景的整合。我们期望Eglobal的这种改编
全球健康科学中代表性不足的少数民族计划可以扩展到其他培训计划
和科学焦点。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Implementing Innovative Approaches to Improve Health Care Delivery Systems for Integrating Communicable and Non-Communicable Diseases Using Tuberculosis and Diabetes as a Model in Tanzania.
- DOI:10.3390/ijerph20176670
- 发表时间:2023-08-29
- 期刊:
- 影响因子:0
- 作者:Mpagama SG;Byashalira KC;Chamba NG;Heysell SK;Alimohamed MZ;Shayo PJ;Kalolo A;Chongolo AM;Gitige CG;Mmbaga BT;Ntinginya NE;Alffenaar JC;Bygbjerg IC;Lillebaek T;Christensen DL;Ramaiya KL
- 通讯作者:Ramaiya KL
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.
- DOI:10.1186/s40814-023-01281-7
- 发表时间:2023-04-01
- 期刊:
- 影响因子:1.7
- 作者:Mpagama, Stellah G. G.;Mvungi, Happiness C. C.;Mbelele, Peter M. M.;Semvua, Hadija H. H.;Liyoyo, Alphonce A. A.;de Guex, Kristen Petros;Sloan, Derek;Kibiki, Gibson S. S.;Boeree, Martin;Phillips, Patrick P. J.;Heysell, Scott K. K.
- 通讯作者:Heysell, Scott K. K.
Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania.
- DOI:10.1093/jacamr/dlac042
- 发表时间:2022-04
- 期刊:
- 影响因子:3.4
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott K Heysell其他文献
Scott K Heysell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott K Heysell', 18)}}的其他基金
Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
培养坦桑尼亚营养不良和结核病交叉领域的研究领导者
- 批准号:
10461564 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
培养坦桑尼亚营养不良和结核病交叉领域的研究领导者
- 批准号:
10588197 - 财政年份:2022
- 资助金额:
$ 15万 - 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
- 批准号:
10084642 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
- 批准号:
10443820 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
- 批准号:
10653094 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
- 批准号:
10265511 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
- 批准号:
10168710 - 财政年份:2018
- 资助金额:
$ 15万 - 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
- 批准号:
10221522 - 财政年份:2018
- 资助金额:
$ 15万 - 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
- 批准号:
10245319 - 财政年份:2018
- 资助金额:
$ 15万 - 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
- 批准号:
10320620 - 财政年份:2018
- 资助金额:
$ 15万 - 项目类别:
相似国自然基金
自动化生产、人工智能与小微企业的市场进入——基于劳动者职业选择的视角
- 批准号:72103098
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
自动化生产、人工智能与小微企业的市场进入---基于劳动者职业选择的视角
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
代际间的职业继承对劳动生产率的影响——基于多部门异质性个体跨代职业选择模型的反事实实验
- 批准号:71703180
- 批准年份:2017
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
人口预期寿命、退休政策如何影响职业选择---基于中国人力资本投资的视角
- 批准号:71403303
- 批准年份:2014
- 资助金额:16.0 万元
- 项目类别:青年科学基金项目
市民化进程中新生代农民工的职业选择与收入差距研究:基于样本自选择的校正
- 批准号:71403023
- 批准年份:2014
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Data Science for Health Discovery and Innovation in Africa Coordinating Centre (DS-I Africa CC)
非洲健康发现和创新数据科学协调中心 (DS-I Africa CC)
- 批准号:
10490976 - 财政年份:2021
- 资助金额:
$ 15万 - 项目类别:
Data Science for Health Discovery and Innovation in Africa Coordinating Centre (DS-I Africa CC)
非洲健康发现和创新数据科学协调中心 (DS-I Africa CC)
- 批准号:
10311570 - 财政年份:2021
- 资助金额:
$ 15万 - 项目类别:
Data Science for Health Discovery and Innovation in Africa Coordinating Centre (DS-I Africa CC)
非洲健康发现和创新数据科学协调中心 (DS-I Africa CC)
- 批准号:
10666686 - 财政年份:2021
- 资助金额:
$ 15万 - 项目类别:
Dysregulation of the Human Ubiquitin Proteasome System in Pediatric Severe Malarial Anemia
儿童严重疟疾贫血中人泛素蛋白酶体系统的失调
- 批准号:
10225622 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别:
Dysregulation of the Human Ubiquitin Proteasome System in Pediatric Severe Malarial Anemia
儿童严重疟疾贫血中人泛素蛋白酶体系统的失调
- 批准号:
10667473 - 财政年份:2020
- 资助金额:
$ 15万 - 项目类别: